1)Lihteh Wu, Teodoro Evans, M Saravia et al:Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome. Jpn J Ophthalmol 53:57-60, 2009
2)Pai SA, Hebri SP, Lootah AM:Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection bevacizumab and triamcinolone acetate. Indian J Ophthalmol 60:551-552, 2012
3)Nowilaty SR, Bouhaimed M:Photodynamic therapy for subfoveal choroidal choroidal neovascularisation in Vogt-Koyanagi-Harada disease. Br J Ophthalmol 90:982-986, 2006
4)宮道大督・浅井竜彦・小出健郎・他:両眼に脈絡膜新生血管を合併した原田病の1例.臨眼 64:1599-1603,2010
5)辻 隆宏・小堀 朗:Vogt-小柳-原田病(VKH)に続発する脈絡膜新生血管症に対してラニビズマブ硝子体注射が奏効した1症例.臨眼 68:367-371,2014
6)Tufail A, Patel PJ, Sivaprasad S et al:Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia:interim analysis of the REPAIR study. Eye 27:709-715, 2013
7)Iacono P, Parodi MB, Papayannis A et al:Intravitreal ranibizumab versus bevacizumab for treatment of myopia choroidal neovascularization. Retina 32:1539-1546, 2012